JPH04500824A - 光老化の作用を回復させるための皮膚の治療方法 - Google Patents

光老化の作用を回復させるための皮膚の治療方法

Info

Publication number
JPH04500824A
JPH04500824A JP2511067A JP51106790A JPH04500824A JP H04500824 A JPH04500824 A JP H04500824A JP 2511067 A JP2511067 A JP 2511067A JP 51106790 A JP51106790 A JP 51106790A JP H04500824 A JPH04500824 A JP H04500824A
Authority
JP
Japan
Prior art keywords
formulas
tables
mathematical
chemical formulas
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2511067A
Other languages
English (en)
Japanese (ja)
Inventor
ハリー，ネイル　フレドリック
ネア，ザイナ
ジェンディメニコ，ジェラルド　ジョーゼフ
ズシ，エフ．クリストファー
スワン，アール．トーマス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastman Kodak Co
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of JPH04500824A publication Critical patent/JPH04500824A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2511067A 1989-07-25 1990-07-19 光老化の作用を回復させるための皮膚の治療方法 Pending JPH04500824A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38494989A 1989-07-25 1989-07-25
US384,949 1989-07-25
US55272790A 1990-07-16 1990-07-16
US552,727 1990-07-16

Publications (1)

Publication Number Publication Date
JPH04500824A true JPH04500824A (ja) 1992-02-13

Family

ID=27010824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2511067A Pending JPH04500824A (ja) 1989-07-25 1990-07-19 光老化の作用を回復させるための皮膚の治療方法

Country Status (6)

Country Link
EP (1) EP0436010A1 (fr)
JP (1) JPH04500824A (fr)
KR (1) KR920700612A (fr)
CA (1) CA2035459A1 (fr)
HU (1) HUT62193A (fr)
WO (1) WO1991001128A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024526745A (ja) * 2021-07-13 2024-07-19 コナゲン インコーポレイテッド レチノイド及びバクチオールのエステルならびにそれらの製剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000937B (el) * 1990-08-24 1993-03-16 Eastman Kodak Co Μέ?οδος δια την αγωγή δέρματος προς αποκατάσταση των αποτελεσμάτων της φωτογηράνσεως.
ATE191444T1 (de) * 1993-12-15 2000-04-15 Avon Prod Inc Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
DE4421433C1 (de) * 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
FR2767823B1 (fr) * 1997-08-27 1999-10-15 Oreal Composes derives d'aminophenol et leur utilisation en cosmetique
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
ATE445589T1 (de) * 2001-05-29 2009-10-15 Chebigen Co Ltd Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
NZ534912A (en) 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
EP2699242B1 (fr) 2011-04-19 2017-11-01 Alfama, Inc. Molécules libérant du monoxyde de carbone et utilisations de celles-ci
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
WO2013019978A1 (fr) * 2011-08-03 2013-02-07 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Portland State University Détection de fluorescence de cystéine et d'homocystéine
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
WO2018152428A1 (fr) * 2017-02-17 2018-08-23 Illustris Pharmaceuticals, Inc. Composés, compositions et utilisation de ceux-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
JPS6163609A (ja) * 1984-09-04 1986-04-01 Takasago Corp チロシナ−ゼ活性阻害剤
JPS61207332A (ja) * 1985-03-12 1986-09-13 Nisshin Kagaku Kk 皮膚疾患治療剤
US4595696A (en) * 1985-09-13 1986-06-17 Usv Pharmaceutical Corp. Polyene compounds useful in the treatment of allergic responses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024526745A (ja) * 2021-07-13 2024-07-19 コナゲン インコーポレイテッド レチノイド及びバクチオールのエステルならびにそれらの製剤

Also Published As

Publication number Publication date
EP0436010A1 (fr) 1991-07-10
KR920700612A (ko) 1992-08-10
HU906129D0 (en) 1991-07-29
WO1991001128A1 (fr) 1991-02-07
HUT62193A (en) 1993-04-28
CA2035459A1 (fr) 1991-01-26

Similar Documents

Publication Publication Date Title
US20090053290A1 (en) Transdermal drug delivery compositions and topical compositions for application on the skin
CA3006143C (fr) Procedes et compositions utilises pour traiter les maladies et les affections dermatologiques
JP3549823B2 (ja) シワを低減するためのアルベリンの用途
US6008254A (en) Method of treating skin disorders with high-strength tretinoin
KR100519638B1 (ko) 지질 장벽 합성을 강화시키는 조성물 및 그 방법
US10869822B2 (en) Compositions for treatment of dermatological diseases and conditions and methods of use thereof
JP2000512298A (ja) 酸性プロテアーゼ酵素と酸性緩衝剤の組合せおよびその使用
JP2012072172A (ja) Ｎ−アセチルアルドースアミン又はｎ−アセチルアミノ酸からなる局所療法用組成物
AU598454B2 (en) Compositions and methods for retarding the effects of aging of the skin
JP7421558B2 (ja) 組織修復に適用されるピルフェニドンを含有する半固体油性医薬組成物
EP0822816B1 (fr) Preparation dermatologique destine au traitement des keratoses actiniques
EA024483B1 (ru) Местная композиция для лечения гиперкератотической кожи
JPH04501122A (ja) ▲ざ▼瘡又は乾癬に関する皮膚の治療のための化合物及び方法
JPH04500824A (ja) 光老化の作用を回復させるための皮膚の治療方法
JP2004508317A (ja) 化粧品組成物および方法
JP2016179958A (ja) 皮膚色素沈着抑制剤
US4189487A (en) Use of pyridine aldehydes for the prevention and treatment of acne vulgaris
US20020176876A1 (en) Topical therapeutic skin care system
JP3550149B2 (ja) セレノアミノ酸の経皮適用による外因性皮膚老化の再生
JPWO2001045697A1 (ja) 皮膚外用剤及び薬剤
WO2020201377A1 (fr) Crème pour le traitement de la peau lésée par le soleil
US6169110B1 (en) Rejuvenating the skin using a combination of vitamin A and alphahydroxy acids
WO1997018804A1 (fr) Rajeunissement de la peau a l'aide d'une combinaison de vitamine a et d'acides alphahydroxy
JP2017088541A (ja) 異常瘢痕形成抑制剤
Steinsapir The chemical peel